![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
![[thumbnail of Original Article]](https://edoc.mdc-berlin.de/style/images/fileicons/application_pdf.png) |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
3MB |
| Item Type: | Review |
|---|---|
| Title: | Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management |
| Creators: |
Sinnecker, T., Kuchling, J.  ORCID: https://orcid.org/0000-0002-7981-2073, Dusek, P. ORCID: https://orcid.org/0000-0003-4877-9642, Dörr, J., Niendorf, T. ORCID: https://orcid.org/0000-0001-7584-6527, Paul, F. ORCID: https://orcid.org/0000-0002-6378-0070 and Wuerfel, J. ORCID: https://orcid.org/0000-0002-0034-8053
|
| Abstract: | Conventional magnetic resonance imaging (MRI) at 1.5 Tesla (T) is limited by modest spatial resolution and signal-to-noise ratio (SNR), impeding the identification and classification of inflammatory central nervous system changes in current clinical practice. Gaining from enhanced susceptibility effects and improved SNR, ultrahigh field MRI at 7 T depicts inflammatory brain lesions in great detail. This review summarises recent reports on 7 T MRI in neuroinflammatory diseases and addresses the question as to whether ultrahigh field MRI may eventually improve clinical decision-making and personalised disease management. |
| Keywords: | 7 Tesla, Ultrahigh field MRI, Multiple sclerosis, Neuromyelitis optica, Susac syndrome, Neuroimmunology, Central vein sign, Cortical lesions, Predictive, Preventive and Personalised Medicine |
| Source: | EPMA Journal |
| ISSN: | 1878-5077 |
| Publisher: | BioMed Central |
| Volume: | 6 |
| Number: | 1 |
| Page Range: | 16 |
| Date: | 27 August 2015 |
| Official Publication: | https://doi.org/10.1186/s13167-015-0038-y |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
